• LAST PRICE
    0.9828
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.9928/ 1
  • Ask / Lots
    1.0200/ 48
  • Open / Previous Close
    0.0000 / 0.9828
  • Day Range
    ---
  • 52 Week Range
    Low 0.9600
    High 4.6400
  • Volume
    354
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 1.06
TimeVolumeCKPT
09:32 ET22081.06
09:36 ET534641.02
09:38 ET40681.04
09:39 ET5001.03
09:41 ET10001.0305
09:43 ET6001.03
09:48 ET15001.0202
09:50 ET11001.0254
09:52 ET10001.025
09:54 ET2001.025
09:57 ET30001.0283
09:59 ET10001.0203
10:01 ET34751.0266
10:03 ET5001.0269
10:08 ET1001.0239
10:10 ET20001.0266
10:12 ET34991.0236
10:14 ET19001.02
10:15 ET22941.0289
10:19 ET6061.0299
10:21 ET1001.02
10:24 ET6001.02
10:28 ET76001.02
10:32 ET1001.02
10:33 ET7001.02
10:35 ET24671.0234
10:37 ET6001.0299
10:46 ET27951.0232
10:50 ET45001.0299
10:51 ET12001.0299
10:55 ET1001.02
11:00 ET2501.0282
11:09 ET9701.0299
11:13 ET10001.0299
11:15 ET15001.03
11:31 ET6101.025
11:33 ET55001.02
11:38 ET60011.02
11:42 ET14001.025
11:47 ET1001.02
11:56 ET36201.03
11:58 ET1001.02
12:12 ET1001.02
12:16 ET23001.02
12:34 ET91001.02
12:36 ET336131
12:38 ET273541.005
12:39 ET15001.005
12:43 ET1001.0001
12:48 ET3001.005
12:52 ET3001.0099
12:54 ET26001.0099
01:01 ET7001.005
01:03 ET37001
01:06 ET11931
01:08 ET79001.005
01:14 ET4001.0099
01:15 ET53901.01
01:21 ET1001.005
01:28 ET1001
01:32 ET4851.0012
01:35 ET4501
01:37 ET2001.01
01:44 ET59331.005
01:48 ET1001
01:50 ET1001
01:57 ET1001
02:02 ET1001
02:04 ET106001
02:06 ET1001.005
02:08 ET1001
02:09 ET77001.0033
02:13 ET2171.005
02:18 ET1001
02:20 ET91211.0099
02:24 ET1001
02:27 ET1001
02:31 ET8961
02:33 ET1001
02:36 ET31891
02:38 ET34451
02:40 ET2001
02:44 ET31001
02:49 ET8001.005
02:51 ET2481
02:54 ET10591.0091
02:56 ET1001.0088
02:58 ET1001
03:00 ET6901.01
03:02 ET20871
03:03 ET2001.005
03:05 ET23451.005
03:07 ET1001
03:09 ET5001
03:14 ET1001
03:16 ET10001.005
03:18 ET102001.005
03:20 ET54751
03:21 ET7001
03:23 ET11001.005
03:25 ET9991.005
03:27 ET3001
03:32 ET4001.01
03:34 ET172921
03:36 ET203581
03:38 ET1250.9985
03:39 ET23000.9924
03:41 ET11000.99
03:43 ET58000.972
03:45 ET113000.972
03:48 ET16000.9909
03:50 ET126160.9919
03:52 ET20000.99
03:54 ET23950.975
03:56 ET53000.9899
03:57 ET42550.98
03:59 ET283230.9828
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCKPT
Checkpoint Therapeutics Inc
90.9M
-1.1x
---
United StatesIMUX
Immunic Inc
91.7M
-1.0x
---
United StatesGALT
Galectin Therapeutics Inc
91.5M
-2.6x
---
United StatesCADL
Candel Therapeutics Inc
97.9M
-4.2x
---
United StatesDBTX
Decibel Therapeutics Inc
98.6M
-1.6x
---
United StatesBIXT
Bioxytran Inc
91.4M
-29.7x
---
As of 2022-09-27

Company Information

Checkpoint Therapeutics, Inc. is a clinical-stage immunotherapy and targeted oncology company that is focused on the acquisition, development and commercialization of treatments for patients with solid tumor cancers. The Company is evaluating its lead antibody product candidate, cosibelimab, which is an anti-programmed death-ligand 1 (PD-L1) antibody licensed from the Dana-Farber Cancer Institute (Dana-Farber) in an ongoing global, open-label, multicohort Phase I clinical trial in checkpoint therapy-naive patients with selected recurrent or metastatic cancers, including ongoing cohorts in locally advanced and metastatic cutaneous squamous cell carcinoma (CSCC) intended to support one or more applications for marketing approval. In addition, it is evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib, which is an epidermal growth factor receptor (EGFR) inhibitor as a treatment for patients with EGFR mutation-positive non-small cell lung cancer (NSCLC).

Contact Information

Headquarters
95 SAWYER ROAD, SUITE 110WALTHAM, MA, United States 02453
Phone
781-652-4500
Fax
302-531-3150

Executives

Chairman of the Board
Michael Weiss
President, Chief Executive Officer, Director
James Oliviero
Chief Financial Officer, Treasurer, Corporate Secretary
William Gray
Director
Lindsay Rosenwald
Independent Director
Christian Bechon

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$90.9M
Revenue (TTM)
$115.0K
Shares Outstanding
92.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.70
EPS
$-0.88
Book Value
$0.35
P/E Ratio
-1.1x
Price/Sales (TTM)
790.5
Price/Cash Flow (TTM)
---
Operating Margin
-62,672.18%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.